| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/01/2011 | US7879576 Culturing marine bacteria and isolating viricidal, bactericididal, fungicidal and antitumor agents from broths |
| 02/01/2011 | US7879574 Folded peptide backbone each end of which is conjugated to a fluorophore, which when cleaved as by digestion with a protease, the fluorophores provide high intensity signals; histology |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879555 Gene expression profiling from FFPE samples |
| 02/01/2011 | US7879547 Method of detecting the presence of asthma or allergies in a patient |
| 02/01/2011 | US7879546 Using human papilloma virus expression profiles as diagnostic/evaluative tool in detection viral induced neoplasia |
| 02/01/2011 | US7879540 Nucleotide sequences modified to present reduced transcriptional characteristics subsequent to gene expression |
| 02/01/2011 | US7879371 using heat resistant elements to transfer heterologous nucleotide sequences into plants; efficient and cost-effective method of introducing Agrobacterium-mediated genetic transformation into plant systems using said caffeine fraction of tea leaves |
| 02/01/2011 | US7879340 blocking, reducing allergic rhinitis via antibodies contacting antigen, by administration of neurotoxin derived from Clostridium; absorbent pledgets, biodegradable carriers; lyophilization; liposomes |
| 02/01/2011 | US7879338 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 02/01/2011 | US7879337 Mutant porcine reproductive and respiratory syndrome virus |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879326 Human neutralizing monoclonal antibodies to H5N1 influenza A virus |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879322 Compositions and methods for use for antibodies against sclerostin |
| 02/01/2011 | US7879321 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 02/01/2011 | CA2551193C Live genetically attenuated malaria vaccine |
| 02/01/2011 | CA2547256C Adenovirus-transfected primary cells and methods of pathway mapping |
| 02/01/2011 | CA2479705C Novel carbonyl reductase, gene encoding the same, and process for producing optically active alcohols using the same |
| 02/01/2011 | CA2445260C Buffer solution for electroporation and a method comprising the use of the same |
| 02/01/2011 | CA2425476C Apparatus for assay, synthesis and storage, and methods of manufacture, use, and manipulation thereof |
| 02/01/2011 | CA2394740C Method for obtaining proteins having improved functional characteristics |
| 02/01/2011 | CA2380550C C type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/01/2011 | CA2372097C Epoxide hydrolases of aspergillus origin |
| 02/01/2011 | CA2359013C Compositions and methods for packaging of alphavirus vectors |
| 02/01/2011 | CA2354508C Streptococcal c5a peptidase vaccine |
| 02/01/2011 | CA2345882C Methods and compositions for the prevention and treatment of anemia |
| 02/01/2011 | CA2321817C Modified forms of pullulanase |
| 02/01/2011 | CA2319084C Novel collectin |
| 02/01/2011 | CA2315887C Free solution ligand interaction molecular separation method |
| 02/01/2011 | CA2312053C Mutant bacillus licheniformis alpha-amylase |
| 02/01/2011 | CA2299282C High expression modules containing two or more tandem copies of a methioninase encoding sequence |
| 02/01/2011 | CA2288943C Ricin-like toxin variants for treatment of cancer, viral or parasitic infections |
| 02/01/2011 | CA2274806C H mutant alpha-amylase enzymes |
| 02/01/2011 | CA2273194C Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 02/01/2011 | CA2222279C Hypoxia inducible factor-1 and method of use |
| 02/01/2011 | CA2188432C Melanoma antigens |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 02/01/2011 | CA1341609C Novel human tissue-type plasminogen activator variant |
| 01/27/2011 | WO2011011796A2 Methods and compositions for improving sugar transport, mixed sugar fermentation, and production of biofuels |
| 01/27/2011 | WO2011011767A1 Method for genome editing |
| 01/27/2011 | WO2011011733A2 Factor replacement therapy |
| 01/27/2011 | WO2011011716A1 Inhibitors of mtor kinase as anti-viral agents |
| 01/27/2011 | WO2011011700A2 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 01/27/2011 | WO2011011678A2 Genetically modified rat models for cytokine-cytokine signaling pathways |
| 01/27/2011 | WO2011011674A2 Production of erythropoiesis stimulating protein using metal ions |
| 01/27/2011 | WO2011011630A2 Nitrilase biocatalysts |
| 01/27/2011 | WO2011011584A1 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein |
| 01/27/2011 | WO2011011568A2 Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms |
| 01/27/2011 | WO2011011486A1 Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
| 01/27/2011 | WO2011011464A2 Constructs and methods for efficient transformation of micro-organisms for production of carbon-based products of interest |
| 01/27/2011 | WO2011011463A2 Manipulation of an alternative respiratory pathway in photo-autotrophs |
| 01/27/2011 | WO2011011447A1 Compositions and methods for silencing ebola virus gene expression |
| 01/27/2011 | WO2011011442A1 Delivery of nucleic acids across membranes |
| 01/27/2011 | WO2011011412A2 Transgenic plants having increased biomass |
| 01/27/2011 | WO2011011292A2 Combinatorial methods for optimizing engineered microorganism function |
| 01/27/2011 | WO2011011273A1 The use of dimerization domain component stacks to modulate plant architecture |
| 01/27/2011 | WO2011011210A1 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods |
| 01/27/2011 | WO2011011175A2 Method for sequencing a polynucleotide template |
| 01/27/2011 | WO2011011092A1 Methods and compositions to reduce oxidative stress |
| 01/27/2011 | WO2011011060A1 Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| 01/27/2011 | WO2011010923A1 Fermentative glycerol-free ethanol production |
| 01/27/2011 | WO2011010870A2 Genetic marker for predicting the survival of a patient with early-stage lung cancer, and method for predicting survival using same |
| 01/27/2011 | WO2011010792A2 Novel strain of paenibacillus sp. hpl-002 for producing alkaline xylanase, novel xylanase enzyme isolated therefrom, and method for producing same |
| 01/27/2011 | WO2011010748A1 Indole derivative and saltiness-strengthening agent containing the derivative |
| 01/27/2011 | WO2011010740A1 Method and kit for detecting microorganisms |
| 01/27/2011 | WO2011010737A1 Guide nucleic acid for cleavage of micro-rna |
| 01/27/2011 | WO2011010717A1 Anti-psk antibody |
| 01/27/2011 | WO2011010714A1 Anionic polymer, polyion complex using anionic polymer, ternary polymer composite, and pharmaceutical composition |
| 01/27/2011 | WO2011010706A1 Fgf21 cis-element binding substance |
| 01/27/2011 | WO2011010639A1 Marker gene for latex tube formation, method for screening for latex tube formation enhancer, and method for enhancing formation of latex tubes in plant |
| 01/27/2011 | WO2011010583A1 Method for screening for oligonucleotide, and oligonucleotide library |
| 01/27/2011 | WO2011010485A1 Process for production of eicosanoid, eicosanoid biosynthesis gene derived from marchantia polymorpha, and use of the gene |
| 01/27/2011 | WO2011010337A1 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins |
| 01/27/2011 | WO2011009938A2 Stambomycin and derivatives, their production and their use as drugs |
| 01/27/2011 | WO2011009801A1 Plants with increased yield |
| 01/27/2011 | WO2011009747A1 Carbohydrate oxidases |
| 01/27/2011 | WO2011009700A1 Improved host cell for the production of a compound of interest |
| 01/27/2011 | WO2011009697A1 Antisense oligomers targeting pcsk9 |
| 01/27/2011 | WO2011009416A1 Biosynthetic gene cluster of nocathiacins and use thereof |
| 01/27/2011 | WO2011009218A1 Raf dimers and uses thereof |
| 01/27/2011 | WO2011009182A2 Isolated nucleic acid molecule, genetic construct, vector, transgenic cell, method for producing a transgenic cell and plant, isolated and purified polypeptide, biodegradable pesticide composition, pest control method, method for producing transgenic strains resistant to insect pests |
| 01/27/2011 | WO2011009173A1 Cancer immunotherapy |
| 01/27/2011 | WO2010138328A3 Light-regulated promoters |
| 01/27/2011 | WO2010134814A3 Means and methods for counteracting polyq expansion disorders |
| 01/27/2011 | WO2010122506A3 Meganuclease variants cleaving at least one target in the genome of a retrovirus and uses thereof |
| 01/27/2011 | WO2010113031A3 Method of altering nucleic acids |
| 01/27/2011 | WO2010105251A3 Non-integrating retroviral vector vaccines |
| 01/27/2011 | WO2010056107A4 Method for identification of a molecular marker linked to the shell gene of oil palm |
| 01/27/2011 | WO2010045512A3 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 01/27/2011 | WO2010009065A3 Amphipathic peptide compositions |
| 01/27/2011 | WO2009153294A8 Use of a tpb salt for the separation of biomolecules |
| 01/27/2011 | WO2009130031A9 Artificial protein scaffolds |
| 01/27/2011 | US20110023195 Engineering single-gene-controlled staygreen potential into plants |
| 01/27/2011 | US20110023194 Engineering zymogen for conditional toxicity |
| 01/27/2011 | US20110023191 Methods for improving crop plant architecture and yield |
| 01/27/2011 | US20110023190 Use of dimerization domain component stacks to modulate plant architecture |